Precision for Medicine and Trialbee Partner to Advance Complex Therapy Trials Toward Precision Medicine

Article

Precision for Medicine and Trialbee are addressing complexities in clinical development through a new partnership that will aim to accelerate the future of precision medicine. Trialbee’s analytics will play a critical role in matching patients to trials conducted by Precision for Medicine and extending recruitment to a more diverse, targeted patient community for the development of complex, personalized medicine.

The partnership expands Precision for Medicine’s ability to match patients, especially those who could be a match for trials in oncology, rare and orphan diseases, including cell or gene therapy trials.

The Precision Site Network, which includes both academic and non-academic sites across North America, Europe, and Australia, can combine with Trialbee’s targeting data to identify untapped populations for trials. This outreach, which can be geotargeted to trial candidates close to that site, aims to enhance patient enrollment with a focus on representative trial participants.

Trialbee HIVE is a real-world data-driven patient matching platform that uses global data assets, look-alike modeling, and digital outreach. Then, interested participants are qualified and enrolled through a nurse qualification process and patient centric experience.

More about their partnership

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
Related Content
© 2024 MJH Life Sciences

All rights reserved.